ClinicalTrials.Veeva

Menu

P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

H

Hossam Hassan Aly Hassan El Sokkary

Status

Completed

Conditions

Endometrial Cancer

Treatments

Other: p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading

Study type

Observational

Funder types

Other

Identifiers

NCT05542940
SOKKARY9

Details and patient eligibility

About

Objective: Calculate the incidence of P53 immunohistochemistry abnormal staining in endometrial cancer and to identify its relation with disease stages, pathological types and grading.

Patients and methods:

100 cases of endometrial cancer will be included in the study, recruited from Alexandria university hospital gyne-oncology unit. Surgical staging, histopathological examination and immunohistochemistry of p53 were done to all cases to calculate the incidence of P53 immunohistochemistry abnormal staining in endometrial cancer and to identify its relation with disease stages, pathological types, grading.

Keywords: P53 immunohistochemistry, endometrial cancer, clinicopathological relation.

Enrollment

100 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • endometrial cancer patients

Exclusion criteria

  • patients unfit for surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems